On Demand Webinar: Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy
Early decisions can either accelerate or undermine the success of advanced therapy programs. From product conception through clinical and commercial scale, proactive planning is essential, especially for programs reliant on cryopreservation and complex manufacturing workflows. This webinar explores how early supply chain strategy decisions can help advanced therapy companies reduce regulatory risk, improve scalability and prepare for key development milestones.
This one-hour roundtable discussion will focus on how early-stage companies can build regulatory readiness from day one by aligning development strategy and supply chain considerations well before pivotal milestones. The featured speakers bring together regulatory and operational perspectives on the decisions that shape long-term program success, including shipping lanes, cryopreservation planning and manufacturing workflow considerations.
We’ll explore:
- How early regulatory and technical decisions shape long term success and why readiness must begin well before clinical milestones
- Why cryopreservation should be treated as a strategic regulatory decision, not simply a logistics or operational consideration
- How to stage development intentionally to balance phase appropriate rigor with future regulatory and commercial expectations
- The importance of cross‑functional alignment and experience in making defensible early decisions across regulatory and supply chain operations